Phonak Audiology Research Center
Aurora, Illinois, 60504, United States
NCT Number: NCT06957730
Hearing impaired participants will be fit with study devices which will have three different hearing aid programs. Speech intelligibility will be measured using validated tests for each of the three hearing aid programs. The order of the hearing aid programs will be randomized across participants and each participant will be blinded as to the programs being tested.
Looking for future studies?
Notify Me18 year–95 year
All sexes
Interventional
Not applicable
Aurora, Illinois, 60504, United States
Program 1 is the current default in the commercially available devices. Programs 2 and 3 are being tested against the current default.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Commercially available receiver-in-canal (RIC) style hearing aid manufactured by Sonova.
Time frame: Day 1 of 1 day study
A list of 20 sentences is presented from a speaker located in front of the participant. At the same time, background noise is presented from the same speaker at various SNR (Signal to Noise Ratio) levels. That is, speech may be presented 5 dB lower/softer than the noise up to 5 dB higher/louder than the noise. The number of words correct is counted and a percentage from the total number of words presented is calculated. A higher percentage is better and indicates better speech intelligibility. This test will be conducted for all three hearing aid program settings.
Time frame: Day 1 of 1 day study
Participants will be asked to choose between two of the hearing aid programs using an A/B comparison, on the following dimensions: clarity, speech naturalness, speech volume, noise intrusion, listening effort, overall sound quality, and preference. Participants will compare program setting 1 to program setting 2 and choose their preference for each above mentioned dimension. Additionally, participants will compare program setting 1 to program setting 3 and choose preference for each dimension. There is no better or worse, but a count will be taken of preferences for each program. Program 2 and 3 are not compared against each other as the objective of the measure is to compare programs 2 and 3 against the current default program (program 1).
Sonova AG
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02298452
Ear Diseases, Hearing Disorders
Stäfa, Canton of Zurich, Switzerland
View Trial DetailsNCT06641999
Ear Diseases, Hearing Disorders
Edegem, Belgium
View Trial DetailsNCT06642935
Ear Diseases, Hearing Disorders
Melbourne, Victoria, Australia
View Trial DetailsNCT07575711
Behavior, Ear Diseases
Samsun, Turkey (Türkiye)
View Trial Details